Interferon lambda 4 impacts the genetic diversity of hepatitis C virus.
M Azim AnsariElihu Aranday-CortesCamilla Lc IpAna da Silva FilipeSiu-Hin LauConnor G G BamfordDavid BonsallAmy TrebesPaolo PiazzaVattipally SreenuVanessa M Cowtonnull nullEmma HudsonRory BowdenArvind H PatelGraham R FosterWilliam Lucien IrvingKosh AgarwalEmma C ThomsonPeter SimmondsPaul KlenermanChris HolmesEleanor BarnesChris Ca SpencerJohn McLauchlanVincent PedergnanaPublished in: eLife (2019)
Hepatitis C virus (HCV) is a highly variable pathogen that frequently establishes chronic infection. This genetic variability is affected by the adaptive immune response but the contribution of other host factors is unclear. Here, we examined the role played by interferon lambda-4 (IFN-λ4) on HCV diversity; IFN-λ4 plays a crucial role in spontaneous clearance or establishment of chronicity following acute infection. We performed viral genome-wide association studies using human and viral data from 485 patients of white ancestry infected with HCV genotype 3a. We demonstrate that combinations of host genetic variants, which determine IFN-λ4 protein production and activity, influence amino acid variation across the viral polyprotein - not restricted to specific viral proteins or HLA restricted epitopes - and modulate viral load. We also observed an association with viral di-nucleotide proportions. These results support a direct role for IFN-λ4 in exerting selective pressure across the viral genome, possibly by a novel mechanism.
Keyphrases
- hepatitis c virus
- immune response
- sars cov
- dendritic cells
- human immunodeficiency virus
- amino acid
- genetic diversity
- end stage renal disease
- endothelial cells
- chronic kidney disease
- liver failure
- gene expression
- escherichia coli
- prognostic factors
- newly diagnosed
- machine learning
- intensive care unit
- cystic fibrosis
- artificial intelligence
- binding protein
- hiv infected
- hepatitis b virus
- peritoneal dialysis